PAVMZ
Income statement / Annual
Last year (2024), PAVmed Inc's total revenue was $3.00 M,
an increase of 22.15% from the previous year.
In 2024, PAVmed Inc's net income was $39.79 M.
See PAVmed Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$3.00 M |
$2.45 M |
$377.00 K |
$500.00 K |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$6.04 M
|
$6.42 M
|
$3.61 M
|
$585.00 K
|
$0.00
|
$14.23 K
|
$9.79 K
|
$7.11 K
|
$3.79 K
|
$0.00
|
| Gross Profit |
-$3.04 M
|
-$3.97 M
|
-$3.24 M
|
-$85.00 K
|
$0.00
|
-$14.23 K
|
-$9.79 K
|
-$7.11 K
|
-$3.79 K
|
$0.00
|
| Gross Profit Ratio |
-1.02
|
-1.62
|
-8.59
|
-0.17
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$5.93 M
|
$14.28 M
|
$25.34 M
|
$19.85 M
|
$10.96 M
|
$6.63 M
|
$4.25 M
|
$2.62 M
|
$1.72 M
|
$489.33 K
|
| General & Administrative Expenses |
$24.52 M
|
$30.95 M
|
$41.41 M
|
$25.57 M
|
$9.60 M
|
$7.66 M
|
$6.31 M
|
$5.42 M
|
$3.93 M
|
$1.29 M
|
| Selling & Marketing Expenses |
$11.63 M
|
$17.58 M
|
$19.32 M
|
$8.90 M
|
$2.79 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$36.15 M
|
$48.53 M
|
$60.73 M
|
$34.46 M
|
$12.39 M
|
$7.66 M
|
$6.31 M
|
$5.42 M
|
$3.93 M
|
$1.29 M
|
| Other Expenses |
-$639.00 K
|
$2.02 M
|
$1.78 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$41.44 M
|
$64.83 M
|
$87.85 M
|
$54.31 M
|
$23.35 M
|
$14.30 M
|
$10.56 M
|
$8.03 M
|
$5.65 M
|
$1.78 M
|
| Cost And Expenses |
$47.48 M
|
$71.25 M
|
$91.46 M
|
$54.89 M
|
$23.35 M
|
$14.30 M
|
$10.56 M
|
$8.03 M
|
$5.65 M
|
$1.78 M
|
| Interest Income |
$254.00 K
|
$505.00 K
|
$169.00 K
|
$0.00
|
$53.00 K
|
$33.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$45.00 K
|
$589.00 K
|
$1.28 M
|
$0.00
|
$53.00 K
|
$32.67 K
|
$2.39 M
|
$724.68 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.20 M
|
$2.93 M
|
$2.46 M
|
$226.00 K
|
$23.00 K
|
$14.23 K
|
$9.79 K
|
$7.11 K
|
$3.79 K
|
$1.78 M
|
| EBITDA |
$29.67 M |
-$75.74 M |
-$99.50 M |
-$55.90 M |
-$23.33 M |
-$16.67 M |
-$12.07 M |
-$11.15 M |
-$5.65 M |
-$1.78 M |
| EBITDA Ratio |
9.91
|
-30.89
|
-263.93
|
-111.8
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-14.85
|
-28.06
|
-241.61
|
-108.79
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$72.91 M
|
-$10.47 M
|
-$12.15 M
|
-$1.73 M
|
-$12.54 M
|
-$2.97 M
|
-$7.61 M
|
-$1.49 M
|
$0.00
|
$0.00
|
| Income Before Tax |
$28.43 M
|
-$79.26 M
|
-$103.24 M
|
-$56.13 M
|
-$35.89 M
|
-$17.27 M
|
-$18.17 M
|
-$9.52 M
|
-$5.65 M
|
-$1.78 M
|
| Income Before Tax Ratio |
9.49
|
-32.33
|
-273.84
|
-112.25
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
$39.79 M
|
-$64.18 M
|
-$88.98 M
|
-$50.35 M
|
-$34.28 M
|
-$15.93 M
|
-$17.97 M
|
-$9.52 M
|
-$5.65 M
|
-$1.78 M
|
| Net Income Ratio |
13.29
|
-26.17
|
-236.03
|
-100.69
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
3.3049 |
-9.164 |
-15.0317 |
-9.7974 |
-10.9302 |
-8.309 |
-12.6261 |
-11.55 |
-6.6 |
-2.0022 |
| EPS Diluted |
0.4961 |
-9.164 |
-15.0317 |
-9.7974 |
-10.9302 |
-8.309 |
-12.6261 |
-11.55 |
-6.6 |
-2.0022 |
| Weighted Average Shares Out |
$9.67 M
|
$7.23 M
|
$5.94 M
|
$5.17 M
|
$3.16 M
|
$2.01 M
|
$1.49 M
|
$899.73 K
|
$864.81 K
|
$887.33 K
|
| Weighted Average Shares Out Diluted |
$65.29 M
|
$7.23 M
|
$5.94 M
|
$5.17 M
|
$3.16 M
|
$2.01 M
|
$1.49 M
|
$899.73 K
|
$864.81 K
|
$887.33 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
